Data-driven Startup 'Pathway' lifts $10 million in Seed Funding round
In its most recent seed investment round, which was managed by TQ Ventures and included participation from Kadmos and Id4, Pathway, a cutting-edge data startup that specializes in creating live AI systems, successfully raised USD 10 million. This follows a $ 5 million fundraising round that was supported by Verge HealthTech Fund and Yamaha Motor Ventures in November 2023.
The new funding will support Pathway's objective to develop AI systems that can reason complexly and make decisions in real time, revolutionizing sectors like healthcare and more. Healthcare workers can find and use medical information more easily thanks to Pathway's platform, which aggregates clinical practice guidelines from millions of evidence-based sources.
The goal of Pathway, which was founded by Chief Science Officer Adrian Kosowski and Chief Technology Officer Jan Chorowski—both of whom had previously worked with physics Nobel Prize winner Geoff Hinton—is to transform artificial intelligence by creating systems that incorporate dynamic sources of both structured and unstructured data. These systems provide real-time insights that support well-informed decision-making by basing decisions on the most recent information available.
370,000 doctors from more than 200 countries have already registered on the site, demonstrating its strong momentum. In a subject that is changing quickly, it helps medical practitioners keep educated by offering over 70,000 recommendations on 30,000 clinical topics.
Businesses in regulated sectors like La Poste and NATO are among Pathway's expanding clientele, underscoring the adaptability and promise of its AI-powered platforms.
Adrian Kosowski, Chief Science Officer says, "We are excited to continue pushing the boundaries of live AI to address real-time, complex decision-making across industries. With the support of our investors and partners, Pathway is poised to make significant strides in improving healthcare and other regulated industries, providing solutions that adapt to constantly changing information."
The new funding will support Pathway's objective to develop AI systems that can reason complexly and make decisions in real time, revolutionizing sectors like healthcare and more. Healthcare workers can find and use medical information more easily thanks to Pathway's platform, which aggregates clinical practice guidelines from millions of evidence-based sources.
The goal of Pathway, which was founded by Chief Science Officer Adrian Kosowski and Chief Technology Officer Jan Chorowski—both of whom had previously worked with physics Nobel Prize winner Geoff Hinton—is to transform artificial intelligence by creating systems that incorporate dynamic sources of both structured and unstructured data. These systems provide real-time insights that support well-informed decision-making by basing decisions on the most recent information available.
370,000 doctors from more than 200 countries have already registered on the site, demonstrating its strong momentum. In a subject that is changing quickly, it helps medical practitioners keep educated by offering over 70,000 recommendations on 30,000 clinical topics.
Businesses in regulated sectors like La Poste and NATO are among Pathway's expanding clientele, underscoring the adaptability and promise of its AI-powered platforms.
Adrian Kosowski, Chief Science Officer says, "We are excited to continue pushing the boundaries of live AI to address real-time, complex decision-making across industries. With the support of our investors and partners, Pathway is poised to make significant strides in improving healthcare and other regulated industries, providing solutions that adapt to constantly changing information."
.jpg "Innovating Legal Solutions to Safeguard your Business")
